Related Experiment Video

Updated: Jun 1, 2026

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
08:32

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells

Published on: March 16, 2017

Endothelial nitric oxide synthase

Takahiko Nakagawa, Richard J Johnson

    Contributions to Nephrology
    |June 11, 2011
    PubMed

    Insights

    Diabetic nephropathy is a major cause of kidney failure. A new mouse model lacking endothelial nitric oxide synthase (eNOS) shows severe kidney injury, suggesting eNOS deficiency is key in diabetic kidney disease.

    Area of Science:

    • Nephrology
    • Endocrinology
    • Cardiovascular Research

    Background:

    • Diabetic nephropathy is a leading cause of end-stage renal disease.
    • Current therapeutic strategies are insufficient.
    • Existing animal models inadequately represent advanced diabetic renal disease.

    Purpose of the Study:

    • To investigate the role of endothelial nitric oxide synthase (eNOS) in the pathogenesis of diabetic nephropathy.
    • To highlight a novel mouse model that mimics advanced human diabetic nephropathy.

    Main Methods:

    • Induction of diabetes in mice genetically modified to lack eNOS (eNOS knockout mice).
    • Observation and analysis of renal injury development in these diabetic eNOS knockout mice.
    • Review of clinical and experimental evidence linking eNOS to diabetic nephropathy.

    Main Results:

    • Diabetic eNOS knockout mice develop severe renal injuries.
    • These injuries closely resemble advanced human diabetic nephropathy.
    • The findings suggest that reduced nitric oxide levels are critical in the disease's development.

    Conclusions:

    • Endothelial nitric oxide synthase (eNOS) plays a crucial role in preventing severe kidney damage in diabetes.
    • Reduced nitric oxide availability is a significant factor in diabetic nephropathy pathogenesis.
    • The diabetic eNOS knockout mouse is a valuable model for studying advanced diabetic kidney disease.

    More Related Videos

    En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries08:58

    En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

    Published on: February 25, 2016

    Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production09:39

    Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production

    Published on: May 19, 2016

    Related Concept Videos

    Nitric Oxide Signaling Pathway01:28

    Nitric Oxide Signaling Pathway

    Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
    Regulation of Angiogenesis and Blood Supply01:24

    Regulation of Angiogenesis and Blood Supply

    Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
    Paracrine Signaling01:21

    Paracrine Signaling

    Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
    Mechanism of Angiogenesis01:10

    Mechanism of Angiogenesis

    Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
    Antihypertensive Drugs: Vasodilators01:23

    Antihypertensive Drugs: Vasodilators

    Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...